I agree that this site is using cookies. You can find further informations here.
X
Abouelfath, A.
113  results:
Search for persons X
?
1

Evaluation of patients' expectation and benefits of subling..:

Caimmi, D. ; Abouelfath, A. ; Lassalle, R....
Revue Française d'Allergologie.  64 (2024)  - p. 104031 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Efficacité en vie réelle des traitements de l'ostéoporose s..:

Bosco-Lévy, P. ; O'Kelly, J. ; Briot, K....
Revue du Rhumatisme.  88 (2021)  - p. A13-A14 , 2021
Link: https://doi.org/10.1016/..
 
?
3

PND25 Cost-Consequence Analysis of Dimethyl Fumarate Versus..:

Bosco-Levy, P. ; Blin, P. ; Lignot-Maleyran, S....
Value in Health.  23 (2020)  - p. S626 , 2020
Link: https://doi.org/10.1016/..
 
?
4

PND75 VALIDATION OF AN ALGORITHM IDENTIFYING RELAPSES IN MU..:

Bosco-Levy, P. ; Blin, P. ; Lignot-Maleyran, S....
Value in Health.  22 (2019)  - p. S750-S751 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Effectiveness and safety of standard and reduced dosages of..:

Blin, P. ; Cottin, Y. ; Dureau-Pournin, C....
Archives of Cardiovascular Diseases Supplements.  11 (2019)  1 - p. 120-121 , 2019
Link: https://doi.org/10.1016/..
 
?
6

P3851Benefit-risk profile of dabigatran compared with vitam..:

Cottin, Y ; Blin, P ; Benichou, J...
European Heart Journal.  39 (2018)  suppl_1 - p. , 2018
Link: https://doi.org/10.1093/..
 
?
7

DS2 - EFFECTIVENESS AND SAFETY OF STANDARD AND REDUCED DOSE..:

Blin, P. ; Cottin, Y. ; Dureau-Pournin, C....
Value in Health.  21 (2018)  - p. S7 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Comparative Effectiveness And Medical Cost of Dabigatran Ve..:

Blin, P ; de Pouvourville, G ; Cottin, Y...
Value in Health.  20 (2017)  9 - p. A608-A609 , 2017
Link: https://doi.org/10.1016/..
 
?
9

P4021Effectiveness and safety of direct oral anticoagulants..:

Cottin, Y. ; Blin, P. ; Benichou, J....
European Heart Journal.  38 (2017)  suppl_1 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
10

Benefit-Risk of Vka for Atrial Fibrillation Before Doac: a ..:

Blin, P ; Dureau-Pournin, C ; Lassalle, R...
Value in Health.  18 (2015)  7 - p. A381 , 2015
Link: https://doi.org/10.1016/..
 
?
11

Benefit-risk of VKA for atrial fibrillation before doac: a ..:

Blin, P. ; Dureau-Pournin, C. ; Lassalle, R....
Clinical Therapeutics.  37 (2015)  8 - p. e11 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Use of the recommended drug combination for secondary preve..:

Bezin, J. ; Pariente, A. ; Lassalle, R....
European Journal of Clinical Pharmacology.  70 (2013)  4 - p. 429-436 , 2013
Link: https://doi.org/10.1007/..
 
?
13

Double-blind randomized pilot trial evaluating the efficacy..:

Léauté-Labrèze, C. ; Dumas de la Roque, E. ; Nacka, F....
British Journal of Dermatology.  169 (2013)  1 - p. 181-183 , 2013
Link: https://doi.org/10.1111/..
 
?
14

Insulin glargine and risk of cancer: a cohort study in the ..:

Blin, P. ; Lassalle, R. ; Dureau-Pournin, C....
Diabetologia.  55 (2012)  3 - p. 644-653 , 2012
Link: https://doi.org/10.1007/..
 
?
15

Adrenal Insufficiency with Inhaled Corticosteroids: An Unde..:

Daveluy, A ; Pollet, C ; Girodet, P-O...
Drug Safety.  30 (2007)  10 - p. 919-990 , 2007
Link: https://doi.org/10.2165/..
 
1-15